The Tumor Microenvironment as a Regulator of Endocrine Resistance in Breast Cancer

Estrogen receptor positive breast neoplasias represent over 70% of diagnosed breast cancers. Depending on the stage at which the tumor is detected, HER2 status and genomic risk, endocrine therapy is combined with either radio, chemo and/or targeted therapy. A growing amount of evidence supports the...

Descripción completa

Detalles Bibliográficos
Autores principales: Diaz Bessone, María Inés, Gattas, María José, Laporte, Tomás, Tanaka, Max, Simian, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694443/
https://www.ncbi.nlm.nih.gov/pubmed/31440208
http://dx.doi.org/10.3389/fendo.2019.00547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694443/
https://www.ncbi.nlm.nih.gov/pubmed/31440208
http://dx.doi.org/10.3389/fendo.2019.00547

Ejemplares similares